Non-viral amplification systems for gene transfer: Vectors based on alphaviruses

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 2, 1999, Pages 244-251

  Smerdou, Cristian ^a   Liljeström, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; DNA VACCINE; RNA; RNA POLYMERASE; VIRUS VECTOR;

ALPHA VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; COST; GENE AMPLIFICATION; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; REPLICON; RNA SYNTHESIS; SEMLIKI FOREST ALPHAVIRUS; SINDBIS VIRUS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS GENOME;

ALPHAVIRUS; ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GENOME, VIRAL; VACCINES, DNA;

ALPHAVIRUS; ANIMALIA; EQUIDAE; PROKARYOTA; SEMLIKI FOREST VIRUS; SINDBIS VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0032965983     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Moelling K: DNA for genetic vaccination and therapy. Cytokines Cell Mol Ther (1997) 3:127-135.
2. Robinson HL: Nucleic acid vaccines: an overview. Vaccine (1997) 15:785-787.
3. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Annu Rev Immunol (1997) 15:617-648.
4. Herweijer H, Wolff H: In vitro transfection with intravascular delivered DNA. Curr Res Mol Ther (1998) 1:504-509.
5. Curr Top Microbiol Immunol (1998) Vol 226.
6. Liljeström P, Garoff H: A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (1991) 9:1356-1361.
7. Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF: Replicon-helper systems from attenuated Venezuelan equine encephalitis virus - Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology (1997) 239:389-401.
8. Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV: Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science (1989) 243:1188-1191.
9. Frolov I, Hoffman TA, Prágai BM, Dryga SA, Huang HV, Schlesinger S, Rice CM: Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci USA (1996) 93:11371-11377.
10. Liljeström P: Alphavirus expression systems. Curr Opin Biotechnol (1994) 5:495-500.
11. Garoff H, Li KJ: Recent advances in gene expression using alphavirus vectors. Curr Opin Biotechnol (1998) 9:464-469.
12. Strauss JH, Strauss EG: The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 58:491-562.
13. Sjöberg EM, Garoff H: The translation-enhancing region of the Semliki Forest virus subgenome is only functional in the virus-infected cell. J Gen Virol (1996) 77:1323-1327.
14. Sjöberg EM, Suomalainen M, Garoff H: A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology (1994) 12:1127-1131.
15. Frolov I, Schlesinger S: Translation of Sindbis virus mRNA: effects of sequences downstream of the initiating codon. J Virol (1994) 68:8111-8117.
16. Liljeström P, Lusa S, Huylebroeck D, Garoff H: In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 65:4107-4113.
17. Rice CM, Levis R, Strauss JH, Huang HV: Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol (1987) 61:3809-3819.
18. Davis NL, Willis LV, Smith JF, Johnston RE: In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology (1989) 171:189-204.
19. Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S: Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol (1993) 67:6439-6446.
20. Levis R, Weiss BG, Tsiang M, Huang H, Schlesinger S: Deletion mapping of Sindbis virus Dl RNAs derived from cDNAs defines the sequences essential for replication and packaging. Cell (1986) 44:137-145.
21. Weiss B, Nitschko H, Ghattas I, Wright R, Schlesinger S: Evidence for specificity in the encapsidation of Sindbis virus RNAs. J Virol (1989) 63:5310-5318.
22. White CL, Thomson M, Dimmock NJ: Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles. J Virol (1998) 72:4320-4326.
23. Raju R, Subramaniam SV, Haijou M: Genesis of Sindbis virus by in vivo recombination of nonreplicative RNA precursors. J Virol (1995) 69:7391-7401.
24. Weiss BG, Schlesinger S: Recombination between Sindbis virus RNAs. J Virol (1991) 65:4017-4025.
25. Haijou M, Hill KR, Subramaniam SV, Hu JY, Raju R: Nonhomologous RNA-RNA recombination events at the 3′ nontranslated region of the Sindbis virus genome: hot spots and utilization of nonviral sequences. J Virol (1996) 70:5153-5164.
26. Berglund P, Sjöberg M, Garoff H, Atkins GJ, Sheahan BJ, Liljeström P: Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnol (1993) 11:916-920.
27. Smerdou C, Liljeström P: Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol (1999) 73:1092-1098.
28. Frolov I, Frolova E, Schlesinger S: Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol (1997) 71:2819-2829.
29. Johanning FW, Conry RM, LoBuglio AF, Wright M, Sumerel LA, Pike MJ, Curiel DT: A Sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expression in vivo. Nucleic Acids Res (1995) 23:1495-1501.
30. Glasgow GM, McGee MM, Tarbatt CJ, D.A. M, Sheahan BJ, Atkins GJ: The Semliki Forest virus vector induces p53-independent apoptosis. J Gen Virol (1998) 79:2405-2410.
31. Frolov I, Schlesinger S: Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J Virol (1994) 68:1721-1727.
32. Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljeström P: Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine (1994) 12:1510-1514.
33. Brand D, Lemiale F, Turbica I, Buzelay L, Brunet S, Barin F: Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. AIDS Res Hum Retrovir (1998) 14:1369-1377.
34. Dalemans W, Delers A, Delmelle C, Denamur F, Meykens R, Thiriart C, Veenstra S, Francotte M, Bruck C, Cohen J: Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA. Ann NY Acad Sci (1995) 772:255-256.
35. Herweijer H, Latendresse JS, Williams P, Zhang GF, Danko I, Schlesinger S, Wolff JA: A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther (1995) 6:1161-1167. This paper describes for the first time the construction of an alphavirus DNA based expression vector.
36. Dubensky Jr TW, Driver DA, Polo JM, Belli BA, Latham EM, Ibanez CE, Chada S, Brumm D, Banks TA, Mento SJ, Jolly DJ, Chang SM: Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol (1996) 70:508-519. This paper describes the construction of several Sindbis virus DNA expression vectors and their characterization in vitro and in vivo. Vectors in which the Sindbis replicon sequence was placed downstream of the CMV IE promoter showed higher expression levels than those in which the MoMLV LTR promoter was used. Expression of foreign antigen (β-galactosidase) was shown in muscle cells of mice immunized with the recombinant Sindbis plasmids. Also specific antibodies could be detected against hepatitis B virus (HBV) antigens when mice were immunized with Sindbis plasmids expressing HB V genes c and e.
37. Perrotta AT, Been MD: A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature (1991) 350:434-436.
38. Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljeström P: Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol (1998) 16:562-565. A SFV DNA/RNA layered expression system was constructed by placing the SFV replicon sequence in a plasmid downstream of the CMV IE promoter. The vector was improved by fusing the SFV capsid translation enhancer to the amino terminal end of the foreign gene. The expression level of foreign proteins from these vectors in transfected cells were studied and compared with those of conventional DNA plasmids. The transient nature of the SFV DNA vector was shown by the induction of cytopathic effect in the transfected cells. Immunization of mice with these vectors showed a great superiority of the SFV plasmids versus the conventional DNA expression systems, since up to 1000-times more of the latter was necessary to induce similar immune responses.
39. DiCiommo DP, Bremner R: Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem (1998) 273:18060-18066. A SFV DNA expression plasmid was constructed by placing the SFV replicon sequence downstream of the CMV IE promoter. The expression levels of foreign protein from this vector were found to be higher than those obtained with a similar Sindbis DNA-based vector. The SFV DNA vector was also used to generate recombinant particles by cotransfecting cells with a CMV IE promoter-driven SFV helper plasmid.
40. Kohno A, Emi N, Kasai M, Tanimoto M, Saito H: Semliki Forest virus-based DNA expression vector - transient protein production followed by cell death. Gene Ther (1998) 5:415-418. This paper describes the construction and characterization of a SFV DNA expression system in which the SFV replicon sequence is placed downstream of the CMV IE promoter. The transient nature of this vector is indirectly shown by using as an indicator of cell death the release of β-galactosidase to the medium in cells transfected with a vector expressing this protein.
41. Nichols WW, Ledwith BJ, Manam SV, Troilo PJ: Potential DNA vaccine integration into host cell genome. Ann NY Acad Sci (1995) 772:30-39.
42. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet (1992) 1:363-369.
43. Mor G, Yamshchikov G, Sedegah M, Takeno M, Wang R, Houghten RA, Hoffman S, Klinman DM: Induction of neonatal tolerance by plasmid DNA vaccination of mice. J Clin Invest (1996) 98:2700-2705.
44. Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA, Catton DJ, Hsu D, Mittelstaedt D, McCormack JE, Karavodin L, Dubensky Jr TW, Chang SM, Banks TA: DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol (1998) 72:950-958. This paper describes the immune responses induced by recombinant Sindbis virus DNA expression vectors expressing the glycoprotein B of herpes simplex virus in mice. Recombinant Sindbis vectors were compared to conventional DNA plasmids expressing the same antigen, and were found to be 100-to 1000-fold more efficient in inducing immune responses in the vaccinated animals. The Sindbis vectors were also able to induce high level of protection from lethal virus challenge in two different murine models at much lower doses than a conventional plasmid.
45. Zhou X, Berglund P, Zhao H, Liljeström P, Jondal M: Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc Natl Acad Sci USA (1995) 92:3009-3013.
46. Lee AH, Suh YS, Sung JH, Yang SH, Sung YC: Comparison of various expression plasmids for the induction of immune response by DNA immunization. Mol Cells (1997) 7:495-501.
47. Vilcek J, Sen GC: Interferons and other cytokines. In: Fields Virology, Fields BN, Knipe DM, Howley PM (Eds). Lippincott-Raven, Philadelphia (1996):375-399.
48. Brandt ER, Linnane AW, Devenish RJ: Expression of IFN A genes in subpopulations of peripheral blood cells. Br J Haematol (1994) 86:717-725.
49. Gates MC, Sheahan BJ, Atkins GJ: The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice. J Gen Virol (1984) 65:73-80.
50. Kaluza G, Lell G, Reinacher M, Stitz L, Willems WR: Neurogenic spread of Semliki Forest virus in mice. Archiv Virol (1987) 93:97-110.
51. Donnelly SM, Sheahan BJ, Atkins GJ: Long-term effects of Semliki Forest virus infection in the mouse central nervous system. Neuropathol Appt Neurobiol (1997) 23:235-241.
52. Agapov EV, Frolov I, Lindebach BD, Prágal BM, Schlesinger S, Rice CM: Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci USA (1998) 95:12989-12994. This paper describes the generation of expression vectors based on a noncytopathic Sindbis virus that can be used as RNA or DNA. These vectors can express reasonable amounts of foreign protein in the transfected cells during extended periods of time.
53. Johnson KL, Ball LA: Replication of Flock House virus RNAs from primary transcripts made in cells by RNA polymerase II. J Virol (1997) 71:3323-3327.